Compare Raytheon Technologies Corp (RTX) vs State Street SPDR S&P Biotech ETF (XBI) Price & Performance

Raytheon Technologies CorpTrade

State Street SPDR S&P Biotech ETFTrade

Price performance (Past 24H)

Key statistics

Raytheon Technologies Corp vs State Street SPDR S&P Biotech ETF — how do they compare? Raytheon Technologies Corp trades at $193.82 (market cap $261.85B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: Raytheon Technologies Corp pays a 1.5% dividend while State Street SPDR S&P Biotech ETF pays none, and State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Raytheon Technologies Corp nearer its low. Which is the better fit depends on your goals.

	RTX	XBI
Market Cap	$261.85B	—
Sector	Industrials	Broad Market / Factor
52-Week High	$212.16	$164.28
52-Week Low	$149.17	$85.16
Enterprise Value	$293.97B	—
Dividend Yield	1.5%	—

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Raytheon Technologies Corp

RTX trades at $193.51, down 0.44% today, with a bullish technical signal and strong analyst support. Recent contract wins, including a $515 million Navy radar deal (PRNewsWire, June 3, 2026), and earnings beats in Q4 2025 and Q1 2026 highlight operational momentum. Revenue growth accelerated to $88.6 billion in 2025, with net income margin improving to 8.03%. The stock faces resistance near $196-$199, with support at $192.

The outlook remains positive given defense spending tailwinds and production expansions, but elevated P/E of 36.48 poses valuation risk. Analysts project 10% upside to a $213 consensus target, with no sell ratings. Key risks include debt levels and geopolitical volatility affecting contracts.

State Street SPDR S&P Biotech ETF

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

RTX

OpenAI and Anthropic boost lobbying to $3.17M in Q2 ahead of IPOs and midtermsCNBC · 10 hours agoNeutral Collins Aerospace and Etihad Engineering form JV to expand aircraft MRO services in Abu Dhabi.PRNewsWire · 11 hours agoBullish Tigerair Taiwan orders 15 Airbus A321neos with fuel-efficient Pratt & Whitney GTF engines.PRNewsWire · 12 hours agoBullish View details →

XBI

Healthcare ETFs lead State Street's top 5 performers with pharma fund gaining 11.7% in the past monthETF Trends · 4 days agoBullish View details →

About Raytheon Technologies Corp

Raytheon Technologies is a diversified aerospace and defense industrial company formed from the merger of United Technologies and Raytheon, with roughly equal exposure as a supplier to commercial aerospace manufactures and to the defense market as a prime and subprime contractor.

About State Street SPDR S&P Biotech ETF

XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.